| http://www.w3.org/ns/prov#value | - Such risks and uncertainties include, among other things, the uncertainties inherent in research and development, including risks related to the progress, timing and results of the clinical trials for dimebon; whether and when any new drug applications for such indication will be filed with regulatory authorities; decisions by regulatory authorities regarding whether and when to approve any new dr
|
